Concord Drugs Ltd.
| BSE: 538965 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE858L01010 |
| BSE 00:00 | 07 Aug | 13.88 |
0.54 (4.05%) |
OPEN
13.98 |
HIGH
13.98 |
LOW
12.81 |
| NSE 05:30 | 01 Jan | Concord Drugs Ltd |
| OPEN | 13.98 |
| PREVIOUS CLOSE | 13.34 |
| VOLUME | 6380 |
| 52-Week high | 22.00 |
| 52-Week low | 11.68 |
| P/E | 36.53 |
| Mkt Cap.(Rs cr) | 12 |
| Buy Price | 13.06 |
| Buy Qty | 1000.00 |
| Sell Price | 13.95 |
| Sell Qty | 450.00 |
Concord Drugs Ltd. (CONCORDDRUGS) - Corporate Action
| ANNOUNCEMENT DATE | PURPOSE | AGM DATE | REMARKS |
| 14-08-2019 | AGM | 30-09-2019 | Concord Drugs Ltd has informed BSE about Outcome of ... |
| 17-08-2018 | AGM | 29-09-2018 | Concord Drugs Ltd has informed BSE that the Register... |
| 28-08-2017 | AGM | 29-09-2017 | AGM 29/09/2017With reference to the subject cited th... |
| 17-08-2016 | AGM | 29-09-2016 | AGM 29.09.2016Concord Drugs Ltd has informed BSE reg... |
| 01-09-2015 | AGM | 30-09-2015 | AGM 30.09.2015Concord Drugs Ltd has informed BSE tha... |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
